A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome

N. Daver, A. Vega-Ruiz, H. M. Kantarjian, Z. Estrov, A. Ferrajoli, S. Kornblau, S. Verstovsek, G. Garcia-Manero, Jorge E. Cortes

Research output: Contribution to journal › Article › peer-review